This shows TOF enhancement postsurgery at each postoperative visit at 3, 6 and 12 months compared with baseline TOF
| TOF at baseline | TOF at 3 m (µL/min mm Hg), % of enhancement | Comparison made to baseline | TOF at 6 m (µL/min mm Hg), % of enhancement | Comparison made to baseline | TOF at 12 (µL/min mm Hg), % of enhancement | Comparison made to baseline | |
| Cataract group (n=16) | 0.15±0.06 | 0.20±0.09 (15) | P=0.05, 95% CI −0.11 to 0.1 | 0.22±0.10 (17) | P=0.02*, 95% CI −0.12 to −0.01 | 0.18±0.07 (10) | P=0.25, 95% CI −0.07 to 0.02 |
| POAG group (n=11) | 0.13±0.08 | 0.15±0.06 (14) | P=0.2, 95% CI −0.07 to 0.01 | 0.17±0.07 (16) | P=0.05*, 95% CI −0.08 to −0.1 | 0.17±0.08 (15) | P=0.07, 95% CI −0.09 to 0.006 |
| Overall (n=27) | 0.14±0.06 | 0.18±0.08 (16) | P=0.02*, 95% CI −0.07 to −0.007 | 0.20±0.09 (15) | P=0.003*, 95% CI −0.09 to −0.02 | 0.17±0.08 (10) | P=0.04*, 95% CI −0.06 to −0.001 |
↵Additionally, the percentage of TOF enhancement is shown.
*Statistically significant.
IOP, intraocular pressure; POAG, primary open angle glaucoma; TOF, tonographic outflow facility.